MET and glioblastoma: •MET, a RTK required for embryonic development andtissue repair, is found to be dysregulated in GBM. The mechanismsinvolved in this dysregulation includes somatic mutations, rearrangement,amplification, and overexpression of MET and hepatocyte growth factor(HGF, ligand for MET) that leads to autocrine loop formation.